Open original FDA record ↗Recall record
- FDA identifier
- Z-1103-05
- Company in FDA record
- Baxter Healthcare Corp.
- FDA classification date
- Aug 6, 2005
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Leaks and disconnection between the bifurcated Y-site and the set tubing may occur and result in underdelivery of medication, blood loss, and a breach of the sterile fluid pathway.
Source facts
- Action
- Baxter sent Urgent Product Recall letters dated 7/6/05 to their customers, to the attention of the Director of Materials Management, via first class mail on the same date. The accounts were informed of the complaints of leaks and disconnection between the bifurcated Y-site and the set tubing, resulting in the possible under delivery of medication, blood loss and a breach of the sterile fluid pathway. The accounts were instructed to examine their inventory for the affected lots of product, remove it from inventory and return it to Baxter for credit. Any questions were directed to the Center for One Baxter at 1-800-422-9837.
- Initiated
- 2005-07-06
- Root cause
- Other
- Terminated
- 2007-01-31
- Distribution
- Arizona, Georgia, Illinois, Michigan, Ohio, Pennsylvania, South Carolina and Texas.
- Recall number
- Z-1103-05
- Recall status
- Terminated
- CDRH record ID
- 40736
- FDA classified
- 2005-08-06
- Recall event number
- 32588